Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon

• Auteurs principaux: Chen C (Auteur), Wu N (Auteur), Watson C (Auteur)
• Format: Livre
• Publié: Dove Medical Press, 2018-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Chao Chen,1 Ning Wu,2 Crystal Watson2 1Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA; 2Value and Access, Biogen, Cambridge, MA, USA Background: Real-world outcomes from staying on an interferon beta (IFNβ) vs switching to anoth...